Try it
General Medicine · Emergency medicine: malignant hyperthermia and NMS
Sample itemWithin an hour of induction with sevoflurane and succinylcholine, a patient develops rigidity, rising end-tidal CO2 and temperature of 40 C. What is the specific treatment?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Intravenous dantrolene
Malignant hyperthermia is triggered by volatile anaesthetics and succinylcholine in susceptible patients with RYR1 mutations, causing uncontrolled calcium release. Dantrolene blocks the ryanodine receptor and is the specific therapy, along with stopping triggers and cooling. Neuroleptic malignant syndrome is treated by stopping the neuroleptic, supportive care and dantrolene or bromocriptine in severe cases.
Option by option
A. Neostigmine
Neostigmine does not treat this condition.
B. Intravenous bromocriptine only
Bromocriptine alone is not the treatment of malignant hyperthermia.
C. Intravenous haloperidol
Haloperidol can trigger NMS and worsen the picture.
D. Intravenous dantrolene (correct)
Correct. Dantrolene is specific for malignant hyperthermia.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More General Medicine questions
- EndocrinologyA 19-year-old with type 1 diabetes presents with vomiting, deep rapid breathing, fruity…
- ElectrolytesWhich is the earliest ECG change in hyperkalaemia?
- Infectious diseaseWhat is the drug of choice for Pneumocystis jirovecii pneumonia in a patient with advanc…
- NeurologyA chronic alcohol user is brought in confused, with nystagmus and an unsteady gait. What…